We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
-3.04%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.01B
AUM Growth
-$17.6M
Cap. Flow
+$25.8M
Cap. Flow %
2.55%
Top 10 Hldgs %
29.84%
Holding
410
New
10
Increased
50
Reduced
72
Closed
29
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
26
Gilead Sciences
GILD
$164B
$15M 1.48%
242,636
+5,506
+2% +$347K
SHY icon
27
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$14.6M 1.45%
+180,180
New +$14.8M
TPYP icon
28
Tortoise North American Pipeline ETF
TPYP
$851M
$13.4M 1.33%
579,678
-585
-0.1% -$14.9K
LDOS icon
29
Leidos
LDOS
$15.9B
$13.3M 1.32%
152,331
+4,160
+3% +$406K
NOC icon
30
Northrop Grumman
NOC
$79.2B
$12.9M 1.28%
27,413
+611
+2% +$291K
LOW icon
31
Lowe's Companies
LOW
$123B
$12.1M 1.2%
64,348
+945
+1% +$184K
APTV icon
32
Aptiv
APTV
$9.76B
$11.8M 1.17%
151,129
+3,805
+3% +$365K
GHYB icon
33
Goldman Sachs Access High Yield Corporate Bond ETF
GHYB
$133M
$11.8M 1.17%
290,476
+268,894
+1,246% +$11.5M
VNLA icon
34
Janus Henderson Short Duration Income ETF
VNLA
$3.35B
$11.7M 1.15%
240,292
-174,290
-42% -$8.48M
UTHR icon
35
United Therapeutics
UTHR
$22B
$11.6M 1.15%
55,467
+679
+1% +$152K
WMT icon
36
Walmart Inc
WMT
$894B
$11.1M 1.1%
255,846
+5,430
+2% +$238K
BIIB icon
37
Biogen
BIIB
$30.5B
$10.7M 1.06%
40,082
+478
+1% +$102K
FV icon
38
First Trust Dorsey Wright Focus 5 ETF
FV
$3.73B
$10.1M 1%
244,854
+9,968
+4% +$440K
LHX icon
39
L3Harris
LHX
$53.3B
$10M 1%
48,323
+2,370
+5% +$547K
GEM icon
40
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.71B
$9.63M 0.95%
372,852
+3,898
+1% +$112K
GBIL icon
41
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.57B
$9.43M 0.93%
94,410
+91,710
+3,397% +$9.15M
GSY icon
42
Invesco Ultra Short Duration ETF
GSY
$3.9B
$9.27M 0.92%
187,729
-178,211
-49% -$8.83M
PLTR icon
43
Palantir
PLTR
$381B
$9.11M 0.9%
+1,120,695
New +$9.97M
INTC icon
44
Intel
INTC
$510B
$8.99M 0.89%
348,893
+2,525
+0.7% +$86.1K
VCSH icon
45
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$8.95M 0.89%
+120,475
New +$9.18M
IGSB icon
46
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$8.69M 0.86%
176,275
+175,375
+19,486% +$8.85M
EEM icon
47
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$8.15M 0.81%
233,746
-11,737
-5% -$458K
JMBS icon
48
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.74B
$7.96M 0.79%
176,878
-211,626
-54% -$10.1M
SHYG icon
49
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
$7.87M 0.78%
+197,112
New +$8.15M
GEN icon
50
Gen Digital
GEN
$16.9B
$7.81M 0.77%
387,715
+7,945
+2% +$184K

Similar funds

Atwood & Palmer's Q3 2022 Portfolio in Review

As of Q3 2022, Atwood & Palmer held 410 positions worth $1.01B, down 1.7% from $1.03B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Atwood & Palmer's Q3 2022 filing shows 10 new, 50 increased, 72 reduced and 29 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 180,180 shares worth $14.6M. The largest sale was Janus Henderson Mortgage-Backed Securities ETF, an estimated $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.

  • Atwood & Palmer's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 180,180 shares worth $14.6M.
  • Atwood & Palmer added most to Goldman Sachs Access High Yield Corporate Bond ETF in Q3 2022, an estimated $11.5M increase.
  • Atwood & Palmer's biggest Q3 2022 reduction was Janus Henderson Mortgage-Backed Securities ETF, cutting an estimated $10.1M.
  • Atwood & Palmer fully exited Comcast in Q3 2022, selling an estimated $177K.
  • Atwood & Palmer's ten largest holdings make up 30% of its $1.01B portfolio in Q3 2022.
  • Atwood & Palmer opened 10 new positions and closed 29 in Q3 2022.
  • Atwood & Palmer's portfolio value fell 1.7% quarter-over-quarter to $1.01B.

Based on Atwood & Palmer's 13F filing for Q3 2022, filed 12 Oct 2022.